Literature DB >> 10510277

Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies.

P Soucek1.   

Abstract

Cytochrome P450 (CYP) 2A6 is the principal human enzyme catalyzing coumarin 7-hydroxylation and is known to be involved in the metabolism of halothane, nicotine, and metabolic activation of butadiene and nitrosamines. In this paper expression of CYP2A6 in Escherichia coli is reported. In order to achieve expression, the N-terminus of protein was modified by PCR mutagenesis. The N-terminal variant with only a single amino acid change showed expression of 210 nmol of CYP2A6/liter of culture. Recombinant CYP2A6 protein was purified to electrophoretic homogeneity and further characterized. Absolute spectra were typical for CYP proteins and indicated low spin characteristics of isolated protein. Due to a hydrophobic segment the N-terminal amino acid sequence of recombinant CYP2A6 was blocked. The N-terminal formylmethionine block was removed by mild acid treatment. Purified CYP2A6 had good catalytic activity toward marker substrate coumarin in a reconstituted system (K(m) = 1.48 +/- 0.37 microM, V(max) = 3.36 +/- 0.18 nmol product/min/nmol CYP). Its activity in the reconstituted system was stimulated by the presence of cytochrome b(5) and glutathione. CYP2A6 was shown to metabolize chlorzoxazone in the reconstituted system with activity of 0.32 nmol of product/min/nmol of CYP, and thus caution should be taken when interpretation of CYP2E1 in vivo phenotyping data is performed. Rabbit polyclonal antibodies were produced against recombinant CYP2A6 and proved to be very useful for immunoblotting and immunoinhibition studies. Availability of this expression system and specific antibodies should facilitate characterization of the role of CYP2A6 in the metabolism of chemicals and in the study biological relevance of genetic polymorphisms of this enzyme. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510277     DOI: 10.1006/abbi.1999.1388

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.

Authors:  Man Ki Ho; Jill C Mwenifumbo; Bin Zhao; Elizabeth M J Gillam; Rachel F Tyndale
Journal:  Pharmacogenet Genomics       Date:  2008-01       Impact factor: 2.089

2.  Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.

Authors:  Rüdiger Kaspera; Suresh B Naraharisetti; Eric A Evangelista; Kristin D Marciante; Bruce M Psaty; Rheem A Totah
Journal:  Biochem Pharmacol       Date:  2011-06-24       Impact factor: 5.858

3.  Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes.

Authors:  Aaron G Bart; Emily E Scott
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

4.  Cytochrome P450 is present in both ferrous and ferric forms in the resting state within intact Escherichia coli and hepatocytes.

Authors:  Wayne A Johnston; Dominic J B Hunter; Christopher J Noble; Graeme R Hanson; Jeanette E Stok; Martin A Hayes; James J De Voss; Elizabeth M J Gillam
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

5.  Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol.

Authors:  Valerie M Kramlinger; Linda B von Weymarn; Sharon E Murphy
Journal:  Chem Biol Interact       Date:  2012-04-01       Impact factor: 5.192

6.  Effect of CYP2A13 active site mutation N297A on metabolism of coumarin and tobacco-specific nitrosamines.

Authors:  Kari E Schlicht; Jeannette Zinggeler Berg; Sharon E Murphy
Journal:  Drug Metab Dispos       Date:  2008-12-12       Impact factor: 3.922

7.  Oxidation of N-Nitrosoalkylamines by human cytochrome P450 2A6: sequential oxidation to aldehydes and carboxylic acids and analysis of reaction steps.

Authors:  Goutam Chowdhury; M Wade Calcutt; F Peter Guengerich
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

8.  CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion.

Authors:  Linda B von Weymarn; Cassandra Retzlaff; Sharon E Murphy
Journal:  J Pharmacol Exp Ther       Date:  2012-08-06       Impact factor: 4.030

9.  Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs.

Authors:  P Soucek; R Zuber; E Anzenbacherová; P Anzenbacher; F P Guengerich
Journal:  BMC Pharmacol       Date:  2001-12-05

10.  Cytochrome b 5 Binds Tightly to Several Human Cytochrome P450 Enzymes.

Authors:  Donghak Kim; Vitchan Kim; Yasuhiro Tateishi; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2021-07-30       Impact factor: 3.579

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.